25 min listen
The Past, Present, and Future of Lupus Treatments
The Past, Present, and Future of Lupus Treatments
ratings:
Length:
16 minutes
Released:
Sep 9, 2021
Format:
Podcast episode
Description
The recent US Food and Drug Administration (FDA) approval of anifrolumab for the treatment of systemic lupus erythematosus (SLE) came a decade after the approval of human monoclonal antibody belimumab. In this episode of the Rheumatology Advisor podcast, we speak with Mary K. Crow, MD, who provides a deeper insight into the evolution of lupus treatments over the years, with a focus on history, barriers in research, information regarding the anifrolumab approval, and the future of drug development in SLE. We also present the perspectives of a patient with lupus; Christele Felix serves as a Patient Advocate for Lupus Studies (PAL) for the Lupus Research Alliance, provides peer support for those interested in learning about clinical trials in lupus, and has presented on various topics, including health disparities, at the American College of Rheumatology (ACR) annual conference.
Released:
Sep 9, 2021
Format:
Podcast episode
Titles in the series (47)
Harnessing the Microbiome to Understand Rheumatic Diseases: There is growing evidence - both in animal models and humans - to suggest the significant role of the microbiome in the etiology of rheumatic diseases. Over the years, multiple microbial agents and changes in the composition of the microbiota have... by Rheum Advisor on Air